STING1 and colorectal carcinoma: STING inhibition significantly decreased both MHCI surface expression on the CRC cells as well as CD8+ T cell activation, strongly indicating that this signaling pathway is one of the mechanisms by which SCFAs promote antitumor immunity in CRCs (Figure 4B).